PIK3CB and cancer: Khalifa et al. synthesized 2-(pyridin-4-yl)quinazolin-4(3H)-ones as potential PI3K inhibitors and assessed their antiproliferative properties against HePG-2, MCF-7, and HCT116 cancer cell lines [129].